0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Sign in to save

Relationship between microplastics and cardiovascular risk factors

CARDIOVASCULAR THERAPY AND PREVENTION 2024 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 45 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
М. Н. Мамедов, Е А Савчук

Summary

This review examines the emerging evidence linking microplastic exposure to cardiovascular risk factors, including endothelial dysfunction, oxidative stress, and inflammation, which are early indicators of heart disease. The authors conclude that microplastics represent a newly recognized environmental cardiovascular risk factor warranting further clinical research.

Body Systems

In recent years, plastic has been widely used in various anthropic activity fields, but its waste pollutes the environment. Under the influence of chemical processes, it decomposes micro- and nanoplas­tics, which enter the human body in various ways. New experimental studies indicate that they can cause a number of cardiovascular disorders, including endothelial cell dysfunction and induction of oxi­dative processes. The article examines the impact of environmental pollution with microplastics on the development of cardiovascular diseases. It is clear that new data on this new risk factor are accumulating and further clinical studies are required.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Microplastics: A Modifiable Cardiac Risk Factor

This review examines the emerging evidence linking microplastic exposure to cardiovascular disease risk factors, including oxidative stress, inflammation, endothelial dysfunction, and thrombosis. The study highlights that micro- and nanoplastics have been identified in coronary artery plaque, suggesting that microplastic exposure may represent a modifiable but currently underrecognized cardiac risk factor.

Article Tier 2

Cardiotoxicity of Microplastics: An Emerging Cardiovascular Risk Factor

This review examines emerging evidence that microplastics may pose risks to cardiovascular health, summarizing findings from laboratory and animal studies. Researchers found that microplastic exposure has been linked to inflammation, oxidative stress, and disrupted heart function in experimental settings. Given that cardiovascular disease is already the leading cause of death globally, the study suggests that microplastics as a potential contributing factor warrant urgent further investigation.

Article Tier 2

Microplastics and Cardiovascular Disease: Should Clinicians Be Paying Attention?

This clinical review summarizes evidence for microplastics as a cardiovascular risk factor, noting that they have been detected in human cardiovascular tissues and that in vitro and animal studies link them to oxidative stress, endothelial dysfunction, and platelet disruption, while cautioning that human evidence remains associative.

Article Tier 2

Micro- and nanoplastics: A new cardiovascular risk factor?

This review examines the growing evidence that micro- and nanoplastics may pose risks to the heart and blood vessels. Studies in animals and cell cultures show that these tiny plastic particles can enter the bloodstream, trigger inflammation, promote blood clotting, and damage blood vessel walls. While human data is still limited, the review suggests that micro- and nanoplastic exposure should be considered a potential new risk factor for cardiovascular disease.

Article Tier 2

Micro-nanoplastics and cardiovascular diseases: evidence and perspectives

Growing evidence suggests that micro- and nanoplastic particles may be a previously unrecognized risk factor for heart disease, as they have been detected in atherosclerotic plaques, heart tissue, and blood clots in humans. Lab studies show these particles can trigger oxidative stress, promote blood clotting, and cause inflammation in blood vessel cells, and their presence in artery plaques has been linked to higher rates of cardiovascular events.

Share this paper